Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Email this article to a friend

A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)

A Bensalem and K Bouzid

from VI Madrid Breast Cancer Conference: Changes in the treatment of breast cancer
Madrid, Spain. 1–3 June 2005

Breast Cancer Research 2005, 7(Suppl 1):P10doi:10.1186/bcr1244

Your name*
Your email address*
Recipient's email address*
(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:
© 1999-2008 BioMed Central Ltd unless otherwise stated < info@breast-cancer-research.com >   Terms and conditions